| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C0002171> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C0031960> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C0034289> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C2930696> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C2987431> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C3179368> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C3505045> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33405372_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Cerrahpaşa Medical Faculty, Department of Dermatology and Venerology, İstanbul University-Cerrahpaşa, Istanbul, Turkey.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/%C3%96zkoca_Defne> <https://research.tib.eu/covid-19/entity/A%C5%9Fk%C4%B1n_%C3%96zge> <https://research.tib.eu/covid-19/entity/Serdaro%C4%9Flu_Server> <https://research.tib.eu/covid-19/entity/Uzun%C3%A7akmak_Tu%C4%9Fba_Kevser>
?:doi	10.1111/dth.14746
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/dth.14746>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Dermatologic therapy
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33405372>
?:pmid	<https://research.tib.eu/covid-19/entity/33405372>
?:pmid	33405372
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.625
?:rankingScore_hIndex	57
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0002171_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C3854325_TREATS_C0002171>
?:title	Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33405372>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33405372>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all